APA stil citiranja

Kolarić, K., Roth, A., Žigman, M., Bradamante, V., & Rogan-Grgas, J. (1993). Phase II trial of cardioprotection with cardioxane (ICRF-187) in patients with advanced breast cancer treated with 5-fluorouracile, doxorubicin and cyclophosphamide (FAC): Phase II trial of cardioprotection with cardioxane (ICRF-187) in patients with advanced breast cancer treated with 5-fluorouracile, doxorubicin and cyclophosphamide (FAC). Libri oncologici, p. 2.

Chicago stil citiranja

Kolarić, Krsto, Anton Roth, Miroslav Žigman, Vlasta Bradamante, and Jadranka Rogan-Grgas. "Phase II trial of cardioprotection with cardioxane (ICRF-187) in patients with advanced breast cancer treated with 5-fluorouracile, doxorubicin and cyclophosphamide (FAC): Phase II trial of cardioprotection with cardioxane (ICRF-187) in patients with advanced breast cancer treated with 5-fluorouracile, doxorubicin and cyclophosphamide (FAC)." 1993: 2.

MLA stil citiranja

Kolarić, Krsto, et al. "Phase II trial of cardioprotection with cardioxane (ICRF-187) in patients with advanced breast cancer treated with 5-fluorouracile, doxorubicin and cyclophosphamide (FAC): Phase II trial of cardioprotection with cardioxane (ICRF-187) in patients with advanced breast cancer treated with 5-fluorouracile, doxorubicin and cyclophosphamide (FAC)." 1993: 2.